GH001

Inhalable Formulation of Psychedelic Drug Rapidly Helped Patients With Treatment-Resistant Depression in Phase 2 Trial
An international team of researchers has published results of a preliminary clinical trial testing a formulation of 5-MeO-DMT, a potent and rapid-acting psychedelic drug, in patients with treatment-… Read More